Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Leigh Perreault

Concepts (338)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Prediabetic State
25
2026
250
6.470
Why?
Diabetes Mellitus, Type 2
52
2026
2623
4.720
Why?
Insulin Resistance
34
2025
1247
3.890
Why?
Obesity
32
2026
3123
3.280
Why?
Hypoglycemic Agents
23
2023
1411
2.780
Why?
Weight Loss
18
2026
857
2.410
Why?
Blood Glucose
32
2026
2357
2.340
Why?
Primary Health Care
9
2026
1768
2.140
Why?
Weight Reduction Programs
4
2026
140
2.120
Why?
Muscle, Skeletal
22
2025
1795
2.080
Why?
Cardiovascular Diseases
15
2020
2218
1.860
Why?
Insulin
20
2024
2524
1.650
Why?
Sphingolipids
7
2024
83
1.550
Why?
Obesity Management
2
2026
12
1.510
Why?
Diabetes Mellitus
11
2023
1101
1.490
Why?
Triglycerides
11
2024
527
1.460
Why?
Glucose Intolerance
8
2020
142
1.350
Why?
Benzhydryl Compounds
3
2017
81
1.340
Why?
Diabetic Angiopathies
3
2017
265
1.320
Why?
Diglycerides
6
2024
66
1.200
Why?
Diabetes Complications
2
2019
219
1.030
Why?
Overweight
7
2022
613
1.000
Why?
Glucosides
2
2017
56
0.990
Why?
Glucagon-Like Peptide 1
3
2023
150
0.920
Why?
Life Style
12
2020
495
0.900
Why?
Exercise
12
2025
2206
0.870
Why?
Metformin
13
2023
328
0.850
Why?
Receptors, Gastrointestinal Hormone
1
2023
7
0.800
Why?
Humans
102
2026
145625
0.790
Why?
Glucose Tolerance Test
15
2021
360
0.790
Why?
Adipose Tissue
5
2025
641
0.780
Why?
Anti-Obesity Agents
2
2024
67
0.770
Why?
Adult
57
2025
40821
0.760
Why?
Glucose Clamp Technique
11
2024
199
0.750
Why?
Cannabidiol
1
2025
142
0.740
Why?
Goals
2
2021
187
0.720
Why?
Dronabinol
1
2025
250
0.710
Why?
Middle Aged
47
2025
36359
0.690
Why?
Nutrition Therapy
1
2022
37
0.680
Why?
Marijuana Use
1
2025
218
0.670
Why?
Liver
4
2014
1859
0.650
Why?
Body Mass Index
13
2025
2446
0.650
Why?
Male
63
2026
73014
0.650
Why?
Female
68
2026
79080
0.640
Why?
Health Equity
1
2023
139
0.630
Why?
Primary Care Nursing
1
2019
4
0.610
Why?
Hyperglycemia
4
2014
381
0.600
Why?
Weight Gain
5
2025
561
0.570
Why?
Peripheral Vascular Diseases
1
2019
102
0.560
Why?
Insulin, Long-Acting
1
2019
65
0.560
Why?
Lipid Metabolism
5
2025
533
0.550
Why?
Infant, Newborn, Diseases
1
2019
113
0.540
Why?
Microvessels
1
2019
98
0.540
Why?
Cannabis
1
2025
519
0.530
Why?
Awareness
1
2019
113
0.530
Why?
Fasting
4
2020
280
0.520
Why?
Policy
1
2018
147
0.510
Why?
Ceramides
5
2024
114
0.500
Why?
Risk Factors
20
2026
10840
0.500
Why?
Risk Management
1
2017
80
0.490
Why?
Precision Medicine
1
2021
462
0.490
Why?
Incretins
2
2021
21
0.480
Why?
Rest
2
2017
126
0.470
Why?
Colorado
6
2026
4588
0.470
Why?
Choristoma
1
2015
20
0.460
Why?
Sleep Deprivation
5
2021
207
0.440
Why?
Insulin-Secreting Cells
2
2010
393
0.420
Why?
Inflammation
1
2025
2915
0.390
Why?
Electronic Health Records
3
2026
1208
0.390
Why?
Sarcolemma
3
2024
33
0.390
Why?
Glucose
4
2023
1051
0.370
Why?
Phenols
1
2013
106
0.370
Why?
Clinical Trials as Topic
1
2017
1062
0.360
Why?
Randomized Controlled Trials as Topic
4
2022
1754
0.350
Why?
Lipids
4
2024
715
0.350
Why?
Aged
18
2025
26251
0.340
Why?
Physical Endurance
5
2020
278
0.330
Why?
Fenofibrate
1
2011
28
0.330
Why?
Athletes
7
2024
430
0.320
Why?
Hypolipidemic Agents
1
2011
89
0.310
Why?
Phosphatidylcholines
2
2024
130
0.310
Why?
Dipeptidyl-Peptidase IV Inhibitors
1
2010
46
0.310
Why?
Glucagon-Like Peptides
2
2022
76
0.310
Why?
Palmitates
1
2009
21
0.310
Why?
Pyrazines
1
2010
94
0.300
Why?
Cross-Sectional Studies
9
2024
5875
0.300
Why?
Hospitalization
1
2019
2468
0.290
Why?
Triazoles
1
2010
190
0.280
Why?
Energy Metabolism
4
2021
930
0.270
Why?
Delphi Technique
3
2026
347
0.270
Why?
Young Adult
13
2025
14240
0.270
Why?
Biomarkers
8
2023
4329
0.270
Why?
Sleep
4
2021
896
0.250
Why?
Risk Reduction Behavior
3
2023
219
0.250
Why?
Sodium-Glucose Transporter 2
2
2017
29
0.250
Why?
Diabetic Nephropathies
2
2020
320
0.250
Why?
Markov Chains
2
2018
128
0.240
Why?
Absenteeism
2
2018
51
0.240
Why?
Sex Characteristics
3
2021
798
0.240
Why?
Clinical Coding
1
2026
28
0.240
Why?
Double-Blind Method
5
2024
2064
0.240
Why?
Health Services
2
2018
112
0.230
Why?
Sex Factors
5
2018
2101
0.230
Why?
Adiponectin
3
2018
243
0.230
Why?
Muscle Fibers, Skeletal
3
2024
214
0.220
Why?
Remission Induction
3
2019
308
0.220
Why?
Follow-Up Studies
6
2021
5397
0.210
Why?
Pilot Projects
2
2021
1878
0.210
Why?
Renal Insufficiency, Chronic
2
2022
639
0.210
Why?
Carnitine
2
2024
91
0.210
Why?
Circadian Rhythm
3
2019
514
0.200
Why?
Lipogenesis
2
2017
62
0.200
Why?
Dietary Fats
3
2020
307
0.200
Why?
Lipoprotein Lipase
1
2004
55
0.200
Why?
United States
10
2026
16041
0.200
Why?
Cross-Over Studies
1
2026
612
0.200
Why?
Hyperinsulinism
1
2024
115
0.190
Why?
Physical Exertion
1
2004
204
0.190
Why?
Oxidation-Reduction
4
2024
1075
0.190
Why?
Healthy Lifestyle
1
2023
38
0.190
Why?
Computer Simulation
2
2018
1014
0.180
Why?
Diet, Reducing
3
2017
90
0.180
Why?
Energy Intake
4
2021
506
0.180
Why?
Socioeconomic Factors
2
2018
1323
0.180
Why?
Biopsy
3
2018
1073
0.180
Why?
Combined Modality Therapy
4
2019
1269
0.180
Why?
Cluster Analysis
1
2023
494
0.170
Why?
Endpoint Determination
2
2019
84
0.170
Why?
Dose-Response Relationship, Drug
3
2024
2018
0.170
Why?
Nephrology
1
2022
59
0.170
Why?
Prevalence
2
2019
2852
0.170
Why?
Glucose Transporter Type 4
1
2021
39
0.170
Why?
Cytosol
2
2020
215
0.160
Why?
Body Weight
4
2024
964
0.160
Why?
Ambulatory Care Facilities
1
2023
267
0.160
Why?
Risk Adjustment
1
2020
83
0.160
Why?
Endocrinologists
1
2020
12
0.150
Why?
New Zealand
1
2019
56
0.150
Why?
Cytosine
1
2019
49
0.150
Why?
Endoplasmic Reticulum
2
2020
268
0.150
Why?
Pragmatic Clinical Trials as Topic
1
2019
135
0.140
Why?
Fatty Acids, Nonesterified
2
2019
154
0.140
Why?
Fatty Liver
1
2021
251
0.140
Why?
Liraglutide
1
2019
32
0.140
Why?
Exercise Test
3
2015
634
0.140
Why?
Models, Econometric
1
2018
35
0.140
Why?
Retinal Diseases
1
2019
101
0.140
Why?
Postprandial Period
1
2019
114
0.130
Why?
Quinolizines
1
1997
9
0.130
Why?
Adolescent
8
2023
22451
0.130
Why?
Treatment Outcome
7
2026
11744
0.130
Why?
Drug Combinations
1
2019
399
0.130
Why?
Nausea
1
1997
111
0.130
Why?
Antiemetics
1
1997
51
0.130
Why?
Cytokines
1
2025
2079
0.130
Why?
Tissue Plasminogen Activator
2
2018
244
0.130
Why?
Cholesterol, HDL
2
2015
201
0.120
Why?
Health Resources
1
2018
130
0.120
Why?
Vomiting
1
1997
131
0.120
Why?
Severity of Illness Index
2
2018
2910
0.120
Why?
Hysterectomy
1
1997
138
0.120
Why?
Odds Ratio
1
2019
1070
0.120
Why?
Referral and Consultation
1
2023
878
0.120
Why?
Patient-Centered Care
1
2021
551
0.120
Why?
Surgical Wound Infection
1
2019
331
0.120
Why?
Delivery of Health Care
1
2023
942
0.120
Why?
Blotting, Western
2
2016
1176
0.120
Why?
Phosphatidylethanolamines
1
2016
78
0.110
Why?
Patient Participation
1
2019
454
0.110
Why?
Eating
2
2021
386
0.110
Why?
Phenotype
1
2024
3186
0.110
Why?
Research Design
2
2019
1139
0.110
Why?
Tandem Mass Spectrometry
2
2024
574
0.110
Why?
Cost-Benefit Analysis
1
2018
632
0.110
Why?
Kidney Diseases
1
2019
427
0.110
Why?
Costs and Cost Analysis
1
2015
216
0.110
Why?
Exercise Therapy
2
2017
486
0.110
Why?
Disease Progression
4
2026
2857
0.100
Why?
Patient Compliance
1
2019
587
0.100
Why?
Sleep Apnea Syndromes
1
2015
98
0.100
Why?
Income
1
2015
205
0.100
Why?
Somatostatin
1
2014
54
0.100
Why?
Hypoglycemia
1
2019
489
0.100
Why?
Logistic Models
1
2019
2112
0.100
Why?
Smoking
2
2012
1478
0.100
Why?
Pneumonia
1
2019
633
0.100
Why?
Indoles
1
1997
509
0.100
Why?
Employment
1
2015
180
0.100
Why?
Fructose
1
2014
132
0.100
Why?
Recovery of Function
2
2015
721
0.100
Why?
Health Personnel
1
2019
750
0.090
Why?
Metabolic Diseases
1
2014
114
0.090
Why?
Cost of Illness
1
2015
322
0.090
Why?
C-Reactive Protein
1
2015
427
0.090
Why?
Oxygen Consumption
4
2016
719
0.090
Why?
Fatty Acids, Monounsaturated
1
2012
55
0.090
Why?
Multicenter Studies as Topic
1
2014
413
0.090
Why?
Models, Theoretical
1
2016
558
0.090
Why?
Homeostasis
1
2016
646
0.090
Why?
Qualitative Research
1
2019
1720
0.090
Why?
Aged, 80 and over
3
2019
8351
0.090
Why?
Adult Children
1
2011
27
0.080
Why?
Placebos
2
2009
190
0.080
Why?
Prospective Studies
3
2019
8087
0.080
Why?
Diabetes, Gestational
1
2015
307
0.080
Why?
Practice Guidelines as Topic
1
2019
1581
0.080
Why?
Mitochondria
1
2018
996
0.080
Why?
Adipocytes
1
2012
223
0.080
Why?
Age Factors
1
2018
3321
0.080
Why?
Health Behavior
2
2023
801
0.080
Why?
Sitagliptin Phosphate
1
2010
31
0.080
Why?
Family Health
1
2011
192
0.080
Why?
Comorbidity
1
2015
1652
0.080
Why?
Health Knowledge, Attitudes, Practice
1
2019
1403
0.080
Why?
Metabolomics
1
2015
737
0.080
Why?
Longevity
1
2011
179
0.080
Why?
Mitochondria, Muscle
2
2021
125
0.070
Why?
C-Peptide
1
2010
191
0.070
Why?
Quality of Life
3
2019
3187
0.070
Why?
Leisure Activities
1
2008
31
0.070
Why?
Menopause
1
2011
327
0.070
Why?
Blood Pressure
1
2014
1761
0.060
Why?
Consensus
2
2020
465
0.060
Why?
Body Composition
1
2011
686
0.060
Why?
Predictive Value of Tests
1
2012
2097
0.060
Why?
Risk Assessment
3
2015
3678
0.060
Why?
Fibrinogen
2
2018
181
0.060
Why?
Cohort Studies
4
2021
6045
0.060
Why?
Multivariate Analysis
1
2009
1531
0.060
Why?
Regression Analysis
2
2019
994
0.050
Why?
Diabetes Mellitus, Type 1
2
2012
3930
0.050
Why?
Mass Screening
1
2013
1300
0.050
Why?
Postoperative Complications
1
1997
2962
0.050
Why?
Aging
1
2015
1983
0.050
Why?
Metabolic Clearance Rate
1
2004
115
0.050
Why?
Health Expenditures
1
1986
196
0.050
Why?
Gene Expression Profiling
2
2023
1790
0.050
Why?
Incidence
3
2019
2910
0.050
Why?
Hormones
1
2004
134
0.050
Why?
Prognosis
2
2023
4331
0.050
Why?
Menstrual Cycle
1
2003
145
0.050
Why?
Retrospective Studies
2
2019
17291
0.050
Why?
Depression
1
2012
1566
0.050
Why?
Parents
1
2011
1393
0.050
Why?
Eligibility Determination
1
2023
72
0.050
Why?
Gastrointestinal Diseases
1
2024
220
0.050
Why?
Mice, Inbred C57BL
1
2013
6021
0.040
Why?
Alcohol Drinking
1
2009
847
0.040
Why?
Lactic Acid
1
2003
295
0.040
Why?
Wakefulness
2
2015
169
0.040
Why?
Animals
3
2024
38030
0.040
Why?
Proportional Hazards Models
2
2017
1318
0.040
Why?
Acute Disease
1
2024
1033
0.040
Why?
Subcellular Fractions
1
2021
73
0.040
Why?
Citric Acid Cycle
1
2021
58
0.040
Why?
Kinetics
1
2004
1553
0.040
Why?
Motor Activity
2
2015
701
0.040
Why?
Sex Hormone-Binding Globulin
1
2020
51
0.040
Why?
Injections, Subcutaneous
1
2021
170
0.040
Why?
Protective Agents
1
2020
43
0.040
Why?
Education
1
2020
102
0.040
Why?
Stearoyl-CoA Desaturase
2
2010
66
0.040
Why?
Proprotein Convertase 9
1
2020
88
0.040
Why?
Analysis of Variance
2
2013
1293
0.040
Why?
Poisson Distribution
1
2019
77
0.040
Why?
Stakeholder Participation
1
2019
90
0.040
Why?
Time Factors
3
2019
7079
0.030
Why?
E-Selectin
1
2018
61
0.030
Why?
Subcutaneous Fat
1
2019
79
0.030
Why?
Probability
1
2019
308
0.030
Why?
Intercellular Adhesion Molecule-1
1
2018
132
0.030
Why?
Chemokine CCL2
1
2018
112
0.030
Why?
Pregnancy
2
2015
7217
0.030
Why?
Primary Cell Culture
1
2019
172
0.030
Why?
Intra-Abdominal Fat
1
2019
101
0.030
Why?
Cell Nucleus
1
2020
584
0.030
Why?
Research
1
2020
421
0.030
Why?
Leptin
1
2018
247
0.030
Why?
Diet
3
2012
1271
0.030
Why?
Case-Control Studies
2
2017
3633
0.030
Why?
Biological Transport
1
2017
423
0.030
Why?
Sequence Analysis, RNA
1
2019
441
0.030
Why?
Adaptation, Physiological
2
2010
567
0.030
Why?
Metabolome
1
2019
390
0.030
Why?
Rats
1
2024
5574
0.030
Why?
Fatty Acids, Unsaturated
1
2016
97
0.030
Why?
Diet, Fat-Restricted
1
2015
79
0.030
Why?
Melatonin
1
2015
164
0.030
Why?
Longitudinal Studies
2
2013
3005
0.030
Why?
Interleukin-6
1
2018
782
0.030
Why?
Kidney
1
2022
1491
0.030
Why?
Blood Glucose Self-Monitoring
1
2020
704
0.030
Why?
Calorimetry
1
2013
69
0.020
Why?
Insulin Receptor Substrate Proteins
1
2012
55
0.020
Why?
Fatty Acids
1
2016
460
0.020
Why?
Risk
1
2015
917
0.020
Why?
Glycerol
1
2012
90
0.020
Why?
Algorithms
1
2020
1843
0.020
Why?
Sleep Wake Disorders
1
2015
314
0.020
Why?
RNA, Messenger
2
2010
2783
0.020
Why?
Calorimetry, Indirect
1
2010
72
0.020
Why?
Antidepressive Agents
1
2012
234
0.020
Why?
Genetic Variation
1
2015
992
0.020
Why?
Palmitic Acid
1
2010
40
0.020
Why?
Surveys and Questionnaires
1
2022
6050
0.020
Why?
Nicotine
1
2012
334
0.020
Why?
Retinoid X Receptor gamma
1
2009
5
0.020
Why?
Gene Expression Regulation
1
2019
2591
0.020
Why?
PPAR alpha
1
2009
56
0.020
Why?
Polysomnography
1
2010
239
0.020
Why?
TOR Serine-Threonine Kinases
1
2012
454
0.020
Why?
Women's Health
1
2011
317
0.020
Why?
Bicycling
1
2010
117
0.020
Why?
Coronary Disease
1
2011
380
0.020
Why?
Phospholipids
1
2010
215
0.020
Why?
Phosphorylation
1
2012
1717
0.020
Why?
Reference Values
1
2009
787
0.020
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
973
0.020
Why?
Adiposity
1
2012
531
0.020
Why?
Mice
1
2024
18266
0.020
Why?
Genetic Predisposition to Disease
1
2015
2455
0.020
Why?
Patient Education as Topic
1
2011
769
0.010
Why?
Genotype
1
2011
1866
0.010
Why?
Infant Care
1
1986
43
0.010
Why?
Infertility
1
1986
61
0.010
Why?
Health Promotion
1
2011
786
0.010
Why?
Delivery, Obstetric
1
1986
164
0.010
Why?
Maternal Health Services
1
1986
99
0.010
Why?
Follicular Phase
1
2003
41
0.010
Why?
Anaerobic Threshold
1
2003
29
0.010
Why?
Spectrophotometry, Ultraviolet
1
2003
81
0.010
Why?
Luteal Phase
1
2003
51
0.010
Why?
Contraception
1
1986
170
0.010
Why?
Catecholamines
1
2003
88
0.010
Why?
Abortion, Induced
1
1986
112
0.010
Why?
Polymorphism, Single Nucleotide
1
2011
2228
0.010
Why?
Heart Rate
1
2003
844
0.010
Why?
Infant, Newborn
1
1986
6449
0.010
Why?
Perreault's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)